Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
about
Déjerine-Sottas syndrome with a silent nucleotide change of myelin protein zero gene.Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease?Dominantly inherited peripheral neuropathies.Inherited peripheral neuropathies.A review of genetic counseling for Charcot Marie Tooth disease (CMT).Pluripotent stem cells for Schwann cell engineering.Tissue culture methods to study neurological disorders: establishment of immortalized Schwann cells from murine disease models.Molecular mechanisms of Charcot-Marie-Tooth neuropathy linked to mutations in human myelin protein P2.Foot pad skin biopsy in mouse models of hereditary neuropathy.MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsPathological classification of equine recurrent laryngeal neuropathyFontan Failure Secondary to Charcot-Marie-Tooth-Induced Phrenic Neuropathy
P2860
Q33876819-2D92149F-84D0-4279-B897-81EC7605CF66Q34713823-E8A62B1E-4A29-477F-B22E-32A3B9C76159Q35193592-B1C2887F-54F8-45DC-8E77-ABB2833318EFQ36822088-6F01897B-613D-49B5-9A44-ADEF3D4E14EBQ38100659-AA57BBE8-E22C-4543-817E-097D3C21D9E1Q38272679-69D9D26E-BE78-4341-B39E-66D5B1CADECDQ40651259-A3867AC0-F514-487B-BE11-D0AC30E132F9Q41140458-5EF53D06-AF4E-44D7-A7BF-F846D26F7076Q42029204-8A4C843B-CF01-4767-8F7D-F2CE243A9E06Q42212358-76B83007-92FC-4551-AECE-73360E9ACB17Q42915875-71B0FBFC-30CA-4DE3-BACB-ED5BC35E1922Q55670527-D8A16F5D-6767-4BE6-AD5B-80D6A36F2D8EQ57178606-61A7E0BD-EC8B-478E-883B-4CBEC3A622D4Q58130386-37FEAA63-0C24-4449-AC17-0C014E83AE4C
P2860
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@ast
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@en
type
label
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@ast
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@en
prefLabel
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@ast
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@en
P2093
P356
P1433
P1476
Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.
@en
P2093
Krajewski KM
Menichella D
Scherer SS
P304
P356
10.1093/BRAIN/123.2.222
P407
P478
123 ( Pt 2)
P577
2000-02-01T00:00:00Z